<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: Osmotherapy with hypertonic saline ameliorates <z:hpo ids='HP_0002181'>cerebral edema</z:hpo> associated with experimental <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>We tested the hypothesis that hypertonic saline exerts its antiedema effect by promoting an efflux of water from brain via the perivascular aquaporin-4 pool </plain></SENT>
<SENT sid="2" pm="."><plain>We used mice with targeted disruption of the gene encoding alpha-syntrophin (alpha-Syn(-/-)) that lack the perivascular aquaporin-4 pool but retain the endothelial pool of this protein </plain></SENT>
<SENT sid="3" pm="."><plain>DESIGN: Prospective laboratory animal study </plain></SENT>
<SENT sid="4" pm="."><plain>SETTING: Research laboratory in a university teaching hospital </plain></SENT>
<SENT sid="5" pm="."><plain>MEASUREMENTS AND MAIN RESULTS: <z:chebi fb="2" ids="5615">Halothane</z:chebi>-anesthetized adult male <z:mp ids='MP_0002169'>wildtype</z:mp> C57B/6 and alpha-Syn(-/-) mice were subjected to 90 min of transient middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> and treated with either a continuous intravenous infusion of 0.9% saline or 3% hypertonic saline (1.5 mL/kg/hr) for 48 hr </plain></SENT>
<SENT sid="6" pm="."><plain>In the first series of experiments (n = 59), increased brain water content analyzed by wet-to-dry ratios in the ischemic hemisphere of <z:mp ids='MP_0002169'>wildtype</z:mp> mice was attenuated after hypertonic saline (79.9% +/- 0.5%; mean +/- <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SEM</z:e>) but not after 0.9% saline (82.3% +/- 1.0%) treatment </plain></SENT>
<SENT sid="7" pm="."><plain>In contrast in alpha-Syn(-/-) mice, hypertonic saline had no effect on the postischemic <z:hpo ids='HP_0000969'>edema</z:hpo> (hypertonic saline: 80.3% +/- 0.7%; 0.9% saline: 80.3% +/- 0.4%) </plain></SENT>
<SENT sid="8" pm="."><plain>In the second series of experiments (n = 32), treatment with hypertonic saline attenuated postischemic blood-brain barrier disruption at 48 hr in <z:mp ids='MP_0002169'>wildtype</z:mp> mice but not in alpha-Syn(-/-) mice; alpha-Syn(-/-) deletion alone had no effect on blood-brain barrier integrity </plain></SENT>
<SENT sid="9" pm="."><plain>In the third series of experiments (n = 34), alpha-Syn(-/-) mice treated with either hypertonic saline or 0.9% saline had smaller <z:mpath ids='MPATH_124'>infarct</z:mpath> volume as compared with their <z:mp ids='MP_0002169'>wildtype</z:mp> counterparts </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: These data demonstrate that 1) osmotherapy with hypertonic saline exerts antiedema effects via the perivascular pool of aquaporin-4, 2) hypertonic saline attenuates blood-brain barrier disruption depending on the presence of perivascular aquaporin-4, and 3) deletion of the perivascular pool of aquaporin-4 alleviates tissue damage after <z:hpo ids='HP_0001297'>stroke</z:hpo>, in mice subjected to osmotherapy and in nontreated mice </plain></SENT>
</text></document>